Arkolith/Insider Trading/VIRX/Form 4

Chevallard Daniel R.

CFO and COOViracta Therapeutics, Inc. (VIRX) · full profile →Form 4 · filed Feb 27, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 27, 2024Sell(S)3K$0.73$2K102K
Feb 25, 2024Option exercise(M)7K—$0106K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 25, 2024Option exercise(M)7K—$034K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-004037) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML